건강보험 적용 대상 의료행위와 의약품을 꾸준히 확대하면서 기존 환자 자기부담금이 이만큼 경감됐다는 의미다.
This means that the existing patient co-payment has been reduced by this amount by steadily expanding medical practices and medicines covered by health insurance.